Pulmonx (LUNG) Cash from Investing Activities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Cash from Investing Activities data on file, last reported at $8.7 million in Q3 2025.

• On a quarterly basis, Cash from Investing Activities rose 29.03% year-over-year to $8.7 million in Q3 2025; TTM through Sep 2025 was $44.6 million, a 6713.76% increase from a year earlier, with the FY2024 full-year figure at $17.5 million, up 970.75% from the prior year.
• Cash from Investing Activities for Q3 2025 stood at $8.7 million, up from $5.5 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for LUNG reached as high as $16.3 million in Q1 2025 and fell as low as -$29.1 million in Q4 2021.
• Historically, Cash from Investing Activities has averaged -$237684.2 across 5 years, with a median of -$727000.0 in 2022.
• Across the five-year window, Cash from Investing Activities sank 4392.11% in 2021 and jumped 2143.18% in 2023, its largest moves.
• Year by year, Cash from Investing Activities stood at -$29.1 million in 2021, then jumped by 97.5% to -$727000.0 in 2022, then sank by 278.95% to -$2.8 million in 2023, then soared by 610.6% to $14.1 million in 2024, then slumped by 38.07% to $8.7 million in 2025.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $8.7 million in Q3 2025, $5.5 million in Q2 2025, and $16.3 million in Q1 2025.